In this Issue:
Minocycline + IFN β-1a in RRMS
MLBG and physical disability progression over 5 years in MS
HRQoL in MS
Effects of comorbidities on DMT use in MS
Long-term safety and efficacy of teriflunomide
High consumption of coffee & decreased MS risk
Long-term treatment with fingolimod in MS
Vitamin D status during pregnancy and risk of MS in offspring
IFN-beta exposure during first trimester is safe in women with MS
Retinal thickness and risk of disability worsening in MS
Please login below to download this issue (PDF)